BVT Call 175 PGR 21.06.2024/ DE000VM58B58 /
| 2024-06-04 8:39:13 AM | Chg.-0.34 | Bid10:00:04 PM | Ask10:00:04 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 3.25EUR | -9.47% | - Bid Size: - |
- Ask Size: - |
Progressive Corporat... | 175.00 USD | 2024-06-21 | Call |
GlobeNewswire
7:30 PM
Quell Therapeutics Advances QEL-001, its Multi-modular Engineered CAR-Treg Cell Therapy, into Effica...
Newsfile Corp
5:03 PM
RETRANSMISSION: Wiz Slots Launches in Canada, Bringing Unique Entertainment Experience to Canadian G...
GlobeNewswire
5:00 PM
Intercept Presents New Sub-Analyses of Phase 3 POISE Data Showcasing the Effect of OCA on Key Liver ...
GlobeNewswire
4:00 PM
Nordic Naturals Joins 40th Annual California Coastal Cleanup to Protect the Health of the Oceans
GlobeNewswire
3:12 PM
18 Genesis HealthCare Affiliated Centers Earn 2024 AHCA/NCAL Bronze National Quality Award
GlobeNewswire
3:00 PM
Tiziana Life Sciences Submits Grant Application to ALS Association to Fund Clinical Trial of Intrana...
GlobeNewswire
1:00 PM
Amicus Therapeutics Receives Prix Galien U.K. Award for Pombiliti® (cipaglucosidase alfa) + Opfolda®...
GlobeNewswire
06-03
MediciNova Announces Data from Phase 1b/2a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Pati...
GlobeNewswire
05-31
TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024...
GlobeNewswire
05-30
Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a R...
GlobeNewswire
05-30
4DMT to Present Interim Data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibro...
GlobeNewswire
05-30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
05-29
Spinogenix Announces FDA Clearance of IND Application for SPG302, a Novel Therapy for the Treatment ...
GlobeNewswire
05-28
Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin...
GlobeNewswire
05-28
Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
GlobeNewswire
05-28
TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple ...
GlobeNewswire
05-25
Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b OR...
GlobeNewswire
05-24
Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Act...
GlobeNewswire
05-24
BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024
GlobeNewswire
05-23
Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Adv...
GlobeNewswire
05-21
Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data ...
